Found: 838
Select item for more details and to access through your institution.
DNA microarray-based characterization and antimicrobial resistance phenotypes of clinical MRSA strains from animal hosts.
- Published in:
- Journal of Veterinary Science, 2020, v. 21, n. 4, p. 1, doi. 10.4142/jvs.2020.21.e54
- By:
- Publication type:
- Article
A Case of Cutaneous Sterile Pyogranuloma/Granuloma Syndrome in a Maltese.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Planar AIEgens with Enhanced Solid‐State Luminescence and ROS Generation for Multidrug‐Resistant Bacteria Treatment.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 25, p. 10265, doi. 10.1002/ange.202001103
- By:
- Publication type:
- Article
Sodium–glucose cotransporter 2 inhibitors as an add-on therapy to insulin for type 1 diabetes mellitus: Meta-analysis of randomized controlled trials.
- Published in:
- Acta Diabetologica, 2021, v. 58, n. 7, p. 869, doi. 10.1007/s00592-021-01686-x
- By:
- Publication type:
- Article
Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: In vitro Susceptibility to Fosfomycin, Nitrofurantoin and Tigecycline.
- Published in:
- Medical Principles & Practice, 2012, v. 21, n. 6, p. 543, doi. 10.1159/000339200
- By:
- Publication type:
- Article
Complete nucleotide sequence of pHN7A8, an F33:A-:B-type epidemic plasmid carrying blaCTX-M-65, fosA3 and rmtB from China.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 1, p. 46
- By:
- Publication type:
- Article
Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 12, p. 2843, doi. 10.1093/jac/dks319
- By:
- Publication type:
- Article
Emergence of resistance to fosfomycin used as adjunct therapy in KPC Klebsiella pneumoniae bacteraemia: report of three cases.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 11, p. 2777, doi. 10.1093/jac/dks270
- By:
- Publication type:
- Article
In vitro efficacy of fosfomycin-containing regimens against methicillin-resistant Staphylococcus aureus in biofilms.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 4, p. 944, doi. 10.1093/jac/dkr535
- By:
- Publication type:
- Article
Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 2, p. 255, doi. 10.1093/jac/dkr466
- By:
- Publication type:
- Article
In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 10, p. 2295, doi. 10.1093/jac/dkr296
- By:
- Publication type:
- Article
Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum β-lactamase (ESBL)-producing Escherichia coli.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 11, p. 2459, doi. 10.1093/jac/dkq346
- By:
- Publication type:
- Article
Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 9, p. 1862, doi. 10.1093/jac/dkq237
- By:
- Publication type:
- Article
Comment on: Cerebrospinal fluid impairs antimicrobial activity of fosfomycin in vitro.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Cerebrospinal fluid impairs antimicrobial activity of fosfomycin in vitro—authors' response.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Fosfomycin susceptibility among extended-spectrum-β-lactamase-producing Escherichia coli in Nottingham, UK.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 5, p. 1076, doi. 10.1093/jac/dkq051
- By:
- Publication type:
- Article
Extracellular concentrations of fosfomycin in lung tissue of septic patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 5, p. 995, doi. 10.1093/jac/dkq070
- By:
- Publication type:
- Article
Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 64, n. 4, p. 829, doi. 10.1093/jac/dkp282
- By:
- Publication type:
- Article
CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 64, n. 4, p. 712, doi. 10.1093/jac/dkp288
- By:
- Publication type:
- Article
Immunomodulatory effects of fosfomycin in an endotoxin model in human blood.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2007, v. 59, n. 2, p. 219
- By:
- Publication type:
- Article
Target site penetration of fosfomycin in critically ill patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 5, p. 1247, doi. 10.1093/jac/dkg187
- By:
- Publication type:
- Article
Antimicrobial resistance of multidrug-resistant Enterobacterales and Acinetobacter baumannii isolates to colistin in a Moroccan hospital.
- Published in:
- Microbes & Infectious Diseases, 2024, v. 5, n. 3, p. 1139, doi. 10.21608/MID.2024.279217.1862
- By:
- Publication type:
- Article
Evaluation of in vitro effect of Fosfomycin on resistant Gramnegative pathogens in urinary tract infection.
- Published in:
- Microbes & Infectious Diseases, 2022, v. 3, n. 2, p. 339, doi. 10.21608/MID.2022.127574.1259
- By:
- Publication type:
- Article
In vitro antimicrobial activity of silver nanoparticles against selected Gram-negative and Gram-positive pathogens.
- Published in:
- Medicine & Pharmacy Reports: Clujul Medical, 2024, v. 97, n. 3, p. 280, doi. 10.15386/mpr-2750
- By:
- Publication type:
- Article
Extended Spectrum Beta Lactamase E. Coli isolated from UTI Patients in Najaf Province, Iraq.
- Published in:
- International Journal of Pharmaceutical Research (09752366), 2020, v. 12, n. 4, p. 673, doi. 10.31838/ijpr/2020.12.04.049
- By:
- Publication type:
- Article
Novel quinoxaline compound against extended-spectrum beta-lactamases producing bacteria.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2024, v. 28, n. 10, p. 3548
- By:
- Publication type:
- Article
Fosfomycin in continuous or prolonged infusion for systemic bacterial infections: a systematic review of its dosing regimen proposal from in vitro, in vivo and clinical studies.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2021, v. 40, n. 6, p. 1117, doi. 10.1007/s10096-021-04181-x
- By:
- Publication type:
- Article
Clinical impact of rapid susceptibility testing on Mueller-Hinton Rapid-SIR directly from urine specimens.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2020, v. 39, n. 7, p. 1373, doi. 10.1007/s10096-020-03855-2
- By:
- Publication type:
- Article
Activity of temocillin against ESBL-, AmpC-, and/or KPC-producing Enterobacterales isolated in Poland.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2020, v. 39, n. 6, p. 1185, doi. 10.1007/s10096-020-03844-5
- By:
- Publication type:
- Article
A pharmacokinetic-pharmacodynamic assessment of oral antibiotics for pyelonephritis.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2019, v. 38, n. 12, p. 2311, doi. 10.1007/s10096-019-03679-9
- By:
- Publication type:
- Article
Risk factors for gentamicin-resistant E. coli in children with community-acquired urinary tract infection.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2019, v. 38, n. 11, p. 2097, doi. 10.1007/s10096-019-03643-7
- By:
- Publication type:
- Article
Prevalence of fosfomycin resistance among ESBL-producing Escherichia coli isolates in the community, Switzerland.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2019, v. 38, n. 5, p. 945, doi. 10.1007/s10096-019-03531-0
- By:
- Publication type:
- Article
The role of therapy with aminoglycoside in the outcomes of kidney transplant recipients infected with polymyxin- and carbapenem-resistant Enterobacteriaceae.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2019, v. 38, n. 4, p. 755, doi. 10.1007/s10096-019-03468-4
- By:
- Publication type:
- Article
Activity of temocillin and 15 other agents, including fosfomycin and colistin, against Enterobacteriaceae in Hong Kong.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2017, v. 36, n. 12, p. 2491, doi. 10.1007/s10096-017-3091-8
- By:
- Publication type:
- Article
Compatibility of fosfomycin with different commercial peritoneal dialysis solutions.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2017, v. 36, n. 11, p. 2237, doi. 10.1007/s10096-017-3051-3
- By:
- Publication type:
- Article
Abrp, a new gene, confers reduced susceptibility to tetracycline, glycylcine, chloramphenicol and fosfomycin classes in Acinetobacter baumannii.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2016, v. 35, n. 8, p. 1371, doi. 10.1007/s10096-016-2674-0
- By:
- Publication type:
- Article
Differential characteristics of healthcare-associated compared to community-acquired febrile urinary tract infections in males.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2015, v. 34, n. 12, p. 2395, doi. 10.1007/s10096-015-2493-8
- By:
- Publication type:
- Article
Testing the mutant selection window hypothesis in vitro and in vivo with Staphylococcus aureus exposed to fosfomycin.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2015, v. 34, n. 4, p. 737, doi. 10.1007/s10096-014-2285-6
- By:
- Publication type:
- Article
Evaluation of a new chromogenic medium, chromID OXA-48, for recovery of carbapenemase-producing Enterobacteriaceae from patients at a university hospital in Turkey.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2015, v. 34, n. 3, p. 519, doi. 10.1007/s10096-014-2255-z
- By:
- Publication type:
- Article
Efficacy of fosfomycin and its combination with linezolid, vancomycin and imipenem in an experimental peritonitis model caused by a Staphylococcus aureus strain with reduced susceptibility to vancomycin.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2011, v. 30, n. 1, p. 89, doi. 10.1007/s10096-010-1058-0
- By:
- Publication type:
- Article
Fosfomycin: an old, new friend?
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2010, v. 29, n. 2, p. 127, doi. 10.1007/s10096-009-0833-2
- By:
- Publication type:
- Article
Fosfomycin in a single dose versus a 7-day course of amoxicillin–clavulanate for the treatment of asymptomatic bacteriuria during pregnancy.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2009, v. 28, n. 12, p. 1457, doi. 10.1007/s10096-009-0805-6
- By:
- Publication type:
- Article
Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2008, v. 27, n. 6, p. 439, doi. 10.1007/s10096-007-0456-4
- By:
- Publication type:
- Article
In vitro activity of fosfomycin alone and in combination with amoxicillin, clarithromycin and metronidazole againstHelicobacter pyloricompared with combined clarithromycin and metronidazole.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2005, v. 24, n. 4, p. 276, doi. 10.1007/s10096-005-1307-9
- By:
- Publication type:
- Article
Impact of the 2019 Food and Drug Administration Guidance for Uncomplicated Urinary Tract Infection on Treatment Response Rates: A Reanalysis of a Clinical Trial of Nitrofurantoin vs Fosfomycin.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 11, p. 1, doi. 10.1093/ofid/ofad557
- By:
- Publication type:
- Article
Multiple-Dose Oral Fosfomycin for Treatment of Complicated Urinary Tract Infections in the Outpatient Setting.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 2, p. N.PAG, doi. 10.1093/ofid/ofaa034
- By:
- Publication type:
- Article
In Vitro Activity of Essential Oils Against Gram-Positive and Gram-Negative Clinical Isolates, Including Carbapenem-Resistant Enterobacteriaceae.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 12, p. N.PAG, doi. 10.1093/ofid/ofz502
- By:
- Publication type:
- Article
720. Efficacy of Fosfomycin for Injection (FOS) vs. Piperacillin–Tazobactam (PIP-TAZ) in Adults with Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP): ZEUS Study Outcomes in Patients With Reduced Study Drug Susceptibility.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S324, doi. 10.1093/ofid/ofz360.788
- By:
- Publication type:
- Article
611. Fosfomycin Resistance of Multidrug-Resistant Escherichia coli and Mechanisms of Fosfomycin Resistance.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S285, doi. 10.1093/ofid/ofz360.680
- By:
- Publication type:
- Article
2263. Fosfomycin Trometerol Use for Complicated UTIs Including Pyelonephritis, a 1-year Review of Outcomes and Prescribing Habits.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S774, doi. 10.1093/ofid/ofz360.1941
- By:
- Publication type:
- Article